Drugs / Mannatide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07655661 | Jul 2026 → Jul 2028 expected | gastric adenocarcinoma, gastroesophageal junction adenocarcinoma | Ming Liu | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mannatide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07655661 ↗ |
| Route | Oral | “administered orally three times daily” NCT07655661 ↗ |